Skip to main content

Panacea

By Rachel McArthur | 12:20 pm | October 22, 2020
The yet-to-be-named programme reportedly “leverages machine learning to optimise a clinical trial’s chances of success” through the analysis of factors such as patient population recruitment and dropout rate.